{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,7]],"date-time":"2026-10-07T19:07:43Z","timestamp":1791400063698,"version":"4.3.3"},"reference-count":100,"publisher":"Springer Science and Business Media LLC","issue":"1-2","license":[{"start":{"date-parts":[[2014,11,12]],"date-time":"2014-11-12T00:00:00Z","timestamp":1415750400000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Immunol Res"],"published-print":{"date-parts":[[2015,2]]},"DOI":"10.1007\/s12026-014-8561-9","type":"journal-article","created":{"date-parts":[[2014,11,14]],"date-time":"2014-11-14T17:09:07Z","timestamp":1415984947000},"page":"53-62","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":167,"title":["Pathogenesis of adult-onset Still\u2019s disease: new insights from the juvenile counterpart"],"prefix":"10.1007","volume":"61","author":[{"given":"Yvan","family":"Jamilloux","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mathieu","family":"Gerfaud-Valentin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fabio","family":"Martinon","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alexandre","family":"Belot","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Thomas","family":"Henry","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Pascal","family":"S\u00e8ve","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2014,11,12]]},"reference":[{"key":"8561_CR1","doi-asserted-by":"crossref","first-page":"708","DOI":"10.1016\/j.autrev.2014.01.058","volume":"13","author":"M Gerfaud-Valentin","year":"2014","unstructured":"Gerfaud-Valentin M, Jamilloux Y, Iwaz J, S\u00e8ve P. Adult-onset Still\u2019s disease. Autoimmun Rev. 2014;13:708\u201322.","journal-title":"Autoimmun Rev"},{"key":"8561_CR2","doi-asserted-by":"crossref","first-page":"784","DOI":"10.1016\/j.cell.2010.03.002","volume":"140","author":"DL Kastner","year":"2010","unstructured":"Kastner DL, Aksentijevich I, Goldbach-Mansky R. Autoinflammatory disease reloaded: a clinical perspective. Cell. 2010;140:784\u201390.","journal-title":"Cell"},{"key":"8561_CR3","doi-asserted-by":"crossref","first-page":"279","DOI":"10.1016\/j.autrev.2005.09.011","volume":"5","author":"AT Borchers","year":"2006","unstructured":"Borchers AT, Selmi C, Cheema G, Keen CL, Shoenfeld Y, Gershwin ME. Juvenile idiopathic arthritis. Autoimmun Rev. 2006;5:279\u201398.","journal-title":"Autoimmun Rev"},{"key":"8561_CR4","doi-asserted-by":"crossref","first-page":"482","DOI":"10.1016\/j.autrev.2011.02.001","volume":"10","author":"Y-T Lin","year":"2011","unstructured":"Lin Y-T, Wang C-T, Gershwin ME, Chiang B-L. The pathogenesis of oligoarticular\/polyarticular vs systemic juvenile idiopathic arthritis. Autoimmun Rev. 2011;10:482\u20139.","journal-title":"Autoimmun Rev"},{"issue":"47\u201360","key":"8561_CR5","first-page":"9","volume":"80","author":"GF Still","year":"1897","unstructured":"Still GF. On a form of chronic joint disease in children. Medico Chir Trans. 1897;80(47\u201360):9.","journal-title":"Medico Chir Trans"},{"key":"8561_CR6","doi-asserted-by":"crossref","first-page":"121","DOI":"10.1136\/ard.30.2.121","volume":"30","author":"EG Bywaters","year":"1971","unstructured":"Bywaters EG. Still\u2019s disease in the adult. Ann Rheum Dis. 1971;30:121\u201333.","journal-title":"Ann Rheum Dis"},{"key":"8561_CR7","doi-asserted-by":"crossref","first-page":"429","DOI":"10.1093\/rheumatology\/34.5.429","volume":"34","author":"SS Uppal","year":"1995","unstructured":"Uppal SS, Pande IR, Kumar A, Kailash S, Sekharan NG, Adya CM, et al. Adult onset Still\u2019s disease in northern India: comparison with juvenile onset Still\u2019s disease. Br J Rheumatol. 1995;34:429\u201334.","journal-title":"Br J Rheumatol"},{"key":"8561_CR8","first-page":"427","volume":"20","author":"F Luthi","year":"2002","unstructured":"Luthi F, Zufferey P, Hofer MF, So AK. \u201cAdolescent-onset Still\u2019s disease\u201d: characteristics and outcome in comparison with adult-onset Still\u2019s disease. Clin Exp Rheumatol. 2002;20:427\u201330.","journal-title":"Clin Exp Rheumatol"},{"key":"8561_CR9","doi-asserted-by":"crossref","first-page":"639","DOI":"10.1007\/s10067-005-0138-5","volume":"25","author":"S Pay","year":"2006","unstructured":"Pay S, T\u00fcrk\u00e7apar N, Kalyoncu M, Sim\u015fek I, Beyan E, Ertenli I, et al. A multicenter study of patients with adult-onset Still\u2019s disease compared with systemic juvenile idiopathic arthritis. Clin Rheumatol. 2006;25:639\u201344.","journal-title":"Clin Rheumatol"},{"key":"8561_CR10","doi-asserted-by":"crossref","first-page":"283","DOI":"10.1136\/ard.49.5.283","volume":"49","author":"J Cabane","year":"1990","unstructured":"Cabane J, Michon A, Ziza JM, Bourgeois P, Bl\u00e9try O, Godeau P, et al. Comparison of long term evolution of adult onset and juvenile onset Still\u2019s disease, both followed up for more than 10 years. Ann Rheum Dis. 1990;49:283\u20135.","journal-title":"Ann Rheum Dis"},{"key":"8561_CR11","doi-asserted-by":"crossref","first-page":"118","DOI":"10.1097\/00005792-199103000-00004","volume":"70","author":"J Pouchot","year":"1991","unstructured":"Pouchot J, Sampalis JS, Beaudet F, Carette S, Decary F, Salusinsky-Sternbach M, et al. Adult Still\u2019s disease: manifestations, disease course, and outcome in 62 patients. Medicine. 1991;70:118\u201336.","journal-title":"Medicine"},{"key":"8561_CR12","doi-asserted-by":"crossref","first-page":"91","DOI":"10.1097\/MD.0000000000000021","volume":"93","author":"M Gerfaud-Valentin","year":"2014","unstructured":"Gerfaud-Valentin M, Maucort-Boulch D, Hot A, Iwaz J, Ninet J, Durieu I, et al. Adult-onset still disease: manifestations, treatment, outcome, and prognostic factors in 57 patients. Medicine. 2014;93:91\u20139.","journal-title":"Medicine"},{"key":"8561_CR13","doi-asserted-by":"crossref","unstructured":"Gerfaud-Valentin M, Hot A, Huissoud C, Durieu I, Broussolle C, Seve P. Adult-onset Still\u2019s disease and pregnancy: about ten cases and review of the literature. Rheumatol Int. 2014;34(6):867\u201371.","DOI":"10.1007\/s00296-013-2765-5"},{"key":"8561_CR14","first-page":"1187","volume":"26","author":"Y Uziel","year":"1999","unstructured":"Uziel Y, Pomeranz A, Brik R, Navon P, Mukamel M, Press J, et al. Seasonal variation in systemic onset juvenile rheumatoid arthritis in Israel. J Rheumatol. 1999;26:1187\u20139.","journal-title":"J Rheumatol"},{"key":"8561_CR15","doi-asserted-by":"crossref","first-page":"416","DOI":"10.1038\/nrrheum.2011.68","volume":"7","author":"ED Mellins","year":"2011","unstructured":"Mellins ED, Macaubas C, Grom AA. Pathogenesis of systemic juvenile idiopathic arthritis: some answers, more questions. Nat Rev Rheumatol. 2011;7:416\u201326.","journal-title":"Nat Rev Rheumatol"},{"key":"8561_CR16","doi-asserted-by":"crossref","first-page":"317","DOI":"10.1016\/j.semarthrit.2012.05.003","volume":"42","author":"JY-Y Lee","year":"2012","unstructured":"Lee JY-Y, Hsu C-K, Liu M-F, Chao S-C. Evanescent and persistent pruritic eruptions of adult-onset still disease: a clinical and pathologic study of 36 patients. Semin Arthritis Rheum. 2012;42:317\u201326.","journal-title":"Semin Arthritis Rheum"},{"key":"8561_CR17","doi-asserted-by":"crossref","first-page":"764","DOI":"10.1136\/ard.47.9.764","volume":"47","author":"JM Wouters","year":"1988","unstructured":"Wouters JM, van der Veen J, van de Putte LB, de Rooij DJ. Adult onset Still\u2019s disease and viral infections. Ann Rheum Dis. 1988;47:764\u20137.","journal-title":"Ann Rheum Dis"},{"key":"8561_CR18","doi-asserted-by":"crossref","first-page":"493","DOI":"10.1136\/ard.59.6.490c","volume":"59","author":"FJ Escudero","year":"2000","unstructured":"Escudero FJ, Len O, Falc\u00f3 V, de Sevilla TF, Sellas A. Rubella infection in adult onset Still\u2019s disease. Ann Rheum Dis. 2000;59:493.","journal-title":"Ann Rheum Dis"},{"key":"8561_CR19","doi-asserted-by":"crossref","first-page":"E105","DOI":"10.1086\/319342","volume":"32","author":"C Perez","year":"2001","unstructured":"Perez C, Artola V. Adult Still\u2019s disease associated with Mycoplasma pneumoniae infection. Clin Infect Dis Off Publ Infect Dis Soc Am. 2001;32:E105\u20136.","journal-title":"Clin Infect Dis Off Publ Infect Dis Soc Am"},{"key":"8561_CR20","doi-asserted-by":"crossref","first-page":"621","DOI":"10.1146\/annurev.immunol.25.022106.141627","volume":"27","author":"SL Masters","year":"2009","unstructured":"Masters SL, Simon A, Aksentijevich I, Kastner DL. Horror autoinflammaticus: the molecular pathophysiology of autoinflammatory disease (*). Annu Rev Immunol. 2009;27:621\u201368.","journal-title":"Annu Rev Immunol"},{"key":"8561_CR21","doi-asserted-by":"crossref","first-page":"624","DOI":"10.1038\/nrrheum.2013.101","volume":"9","author":"G Grateau","year":"2013","unstructured":"Grateau G, Hentgen V, Stojanovic KS, J\u00e9ru I, Amselem S, Steichen O. How should we approach classification of autoinflammatory diseases? Nat Rev Rheumatol. 2013;9:624\u20139.","journal-title":"Nat Rev Rheumatol"},{"key":"8561_CR22","doi-asserted-by":"crossref","first-page":"77","DOI":"10.1016\/j.autrev.2012.07.026","volume":"12","author":"I Kon\u00e9-Paut","year":"2012","unstructured":"Kon\u00e9-Paut I, Piram M. Targeting interleukin-1\u03b2 in CAPS (cryopyrin-associated periodic) syndromes: what did we learn? Autoimmun Rev. 2012;12:77\u201380.","journal-title":"Autoimmun Rev"},{"key":"8561_CR23","doi-asserted-by":"crossref","unstructured":"Hoffman HM. Therapy of autoinflammatory syndromes. J Allergy Clin Immunol. 2009;124:1129\u20131138; quiz 1139\u20131140.","DOI":"10.1016\/j.jaci.2009.11.001"},{"key":"8561_CR24","doi-asserted-by":"crossref","first-page":"1596","DOI":"10.1136\/ard.2005.046904","volume":"65","author":"J-B Arlet","year":"2006","unstructured":"Arlet J-B, Le THD, Marinho A, Amoura Z, Wechsler B, Papo T, et al. Reactive haemophagocytic syndrome in adult-onset Still\u2019s disease: a report of six patients and a review of the literature. Ann Rheum Dis. 2006;65:1596\u2013601.","journal-title":"Ann Rheum Dis"},{"key":"8561_CR25","doi-asserted-by":"crossref","first-page":"119","DOI":"10.1080\/03009740310000148","volume":"32","author":"J-K Min","year":"2003","unstructured":"Min J-K, Cho C-S, Kim H-Y, Oh E-J. Bone marrow findings in patients with adult Still\u2019s disease. Scand J Rheumatol. 2003;32:119\u201321.","journal-title":"Scand J Rheumatol"},{"key":"8561_CR26","doi-asserted-by":"crossref","first-page":"1469","DOI":"10.1002\/art.1780241203","volume":"24","author":"R Terkeltaub","year":"1981","unstructured":"Terkeltaub R, Esdaile JM, D\u00e9cary F, Harth M, Lister J, Lapointe N. HLA-Bw35 and prognosis in adult Still\u2019s disease. Arthritis Rheum. 1981;24:1469\u201372.","journal-title":"Arthritis Rheum"},{"key":"8561_CR27","first-page":"489","volume":"21","author":"CI Joung","year":"2003","unstructured":"Joung CI, Lee HS, Lee SW, Kim CG, Song YH, Jun JB, et al. Association between HLA-DR B1 and clinical features of adult onset Still\u2019s disease in Korea. Clin Exp Rheumatol. 2003;21:489\u201392.","journal-title":"Clin Exp Rheumatol"},{"key":"8561_CR28","doi-asserted-by":"crossref","first-page":"1369","DOI":"10.1172\/JCI2629","volume":"102","author":"D Fishman","year":"1998","unstructured":"Fishman D, Faulds G, Jeffery R, Mohamed-Ali V, Yudkin JS, Humphries S, et al. The effect of novel polymorphisms in the interleukin-6 (IL-6) gene on IL-6 transcription and plasma IL-6 levels, and an association with systemic-onset juvenile chronic arthritis. J Clin Invest. 1998;102:1369\u201376.","journal-title":"J Clin Invest"},{"key":"8561_CR29","first-page":"912","volume":"28","author":"JC M\u00f6ller","year":"2010","unstructured":"M\u00f6ller JC, Paul D, Ganser G, Range U, Gahr M, Kelsch R, et al. IL10 promoter polymorphisms are associated with systemic onset juvenile idiopathic arthritis (SoJIA). Clin Exp Rheumatol. 2010;28:912\u20138.","journal-title":"Clin Exp Rheumatol"},{"key":"8561_CR30","doi-asserted-by":"crossref","first-page":"349","DOI":"10.1038\/gene.2008.24","volume":"9","author":"CJW Stock","year":"2008","unstructured":"Stock CJW, Ogilvie EM, Samuel JM, Fife M, Lewis CM, Woo P. Comprehensive association study of genetic variants in the IL-1 gene family in systemic juvenile idiopathic arthritis. Genes Immun. 2008;9:349\u201357.","journal-title":"Genes Immun"},{"key":"8561_CR31","doi-asserted-by":"crossref","first-page":"394","DOI":"10.1038\/sj.gene.6363922","volume":"3","author":"T Sugiura","year":"2002","unstructured":"Sugiura T, Kawaguchi Y, Harigai M, Terajima-Ichida H, Kitamura Y, Furuya T, et al. Association between adult-onset Still\u2019s disease and interleukin-18 gene polymorphisms. Genes Immun. 2002;3:394\u20139.","journal-title":"Genes Immun"},{"key":"8561_CR32","doi-asserted-by":"crossref","first-page":"R65","DOI":"10.1186\/ar4239","volume":"15","author":"F-F Wang","year":"2013","unstructured":"Wang F-F, Huang X-F, Shen N, Leng L, Bucala R, Chen S-L, et al. A genetic role for macrophage migration inhibitory factor (MIF) in adult-onset Still\u2019s disease. Arthritis Res Ther. 2013;15:R65.","journal-title":"Arthritis Res Ther"},{"key":"8561_CR33","doi-asserted-by":"crossref","first-page":"1505","DOI":"10.1002\/art.23437","volume":"58","author":"M Gattorno","year":"2008","unstructured":"Gattorno M, Piccini A, Lasigli\u00e8 D, Tassi S, Brisca G, Carta S, et al. The pattern of response to anti-interleukin-1 treatment distinguishes two subsets of patients with systemic-onset juvenile idiopathic arthritis. Arthritis Rheum. 2008;58:1505\u201315.","journal-title":"Arthritis Rheum"},{"key":"8561_CR34","first-page":"60","volume":"31","author":"JJ Kim","year":"2013","unstructured":"Kim JJ, Kim J-K, Shim S-C, Choe J-Y, Kim T-H, Jun J-B, et al. MEFV gene mutations and their clinical significance in Korean patients with adult-onset Still\u2019s disease. Clin Exp Rheumatol. 2013;31:60\u20133.","journal-title":"Clin Exp Rheumatol"},{"key":"8561_CR35","first-page":"2422","volume":"30","author":"J-H Choi","year":"2003","unstructured":"Choi J-H, Suh C-H, Lee Y-M, Suh Y-J, Lee S-K, Kim S-S, et al. Serum cytokine profiles in patients with adult onset Still\u2019s disease. J Rheumatol. 2003;30:2422\u20137.","journal-title":"J Rheumatol"},{"key":"8561_CR36","doi-asserted-by":"crossref","first-page":"156","DOI":"10.3109\/03009742.2011.644325","volume":"41","author":"A Komiya","year":"2012","unstructured":"Komiya A, Matsui T, Nogi S, Iwata K, Futami H, Takaoka H, et al. Neutrophil CD64 is upregulated in patients with active adult-onset Still\u2019s disease. Scand J Rheumatol. 2012;41:156\u20138.","journal-title":"Scand J Rheumatol"},{"key":"8561_CR37","doi-asserted-by":"crossref","first-page":"477","DOI":"10.1093\/rheumatology\/38.5.477","volume":"38","author":"K Matsui","year":"1999","unstructured":"Matsui K, Tsuchida T, Hiroishi K, Tominaga K, Hayashi N, Hada T, et al. High serum level of macrophage-colony stimulating factor (M-CSF) in adult-onset Still\u2019s disease. Rheumatology. 1999;38:477\u20138.","journal-title":"Rheumatology"},{"key":"8561_CR38","doi-asserted-by":"crossref","first-page":"1479","DOI":"10.1084\/jem.20050473","volume":"201","author":"V Pascual","year":"2005","unstructured":"Pascual V, Allantaz F, Arce E, Punaro M, Banchereau J. Role of interleukin-1 (IL-1) in the pathogenesis of systemic onset juvenile idiopathic arthritis and clinical response to IL-1 blockade. J Exp Med. 2005;201:1479\u201386.","journal-title":"J Exp Med"},{"key":"8561_CR39","doi-asserted-by":"crossref","first-page":"1954","DOI":"10.1002\/art.22644","volume":"56","author":"EM Ogilvie","year":"2007","unstructured":"Ogilvie EM, Khan A, Hubank M, Kellam P, Woo P. Specific gene expression profiles in systemic juvenile idiopathic arthritis. Arthritis Rheum. 2007;56:1954\u201365.","journal-title":"Arthritis Rheum"},{"key":"8561_CR40","doi-asserted-by":"crossref","first-page":"2102","DOI":"10.1002\/art.24601","volume":"60","author":"MG Barnes","year":"2009","unstructured":"Barnes MG, Grom AA, Thompson SD, Griffin TA, Pavlidis P, Itert L, et al. Subtype-specific peripheral blood gene expression profiles in recent-onset juvenile idiopathic arthritis. Arthritis Rheum. 2009;60:2102\u201312.","journal-title":"Arthritis Rheum"},{"key":"8561_CR41","doi-asserted-by":"crossref","first-page":"R39","DOI":"10.1186\/ar4193","volume":"15","author":"D-Y Chen","year":"2013","unstructured":"Chen D-Y, Lin C-C, Chen Y-M, Lan J-L, Hung W-T, Chen H-H, et al. Involvement of TLR7 MyD88-dependent signaling pathway in the pathogenesis of adult-onset Still\u2019s disease. Arthritis Res Ther. 2013;15:R39.","journal-title":"Arthritis Res Ther"},{"key":"8561_CR42","doi-asserted-by":"crossref","first-page":"2305","DOI":"10.1093\/rheumatology\/keq284","volume":"49","author":"D-Y Chen","year":"2010","unstructured":"Chen D-Y, Chen Y-M, Lan J-L, Lin C-C, Chen H-H, Hsieh C-W. Potential role of Th17 cells in the pathogenesis of adult-onset Still\u2019s disease. Rheumatology. 2010;49:2305\u201312.","journal-title":"Rheumatology"},{"key":"8561_CR43","doi-asserted-by":"crossref","first-page":"883","DOI":"10.1002\/art.24349","volume":"60","author":"M Frosch","year":"2009","unstructured":"Frosch M, Ahlmann M, Vogl T, Wittkowski H, Wulffraat N, Foell D, et al. The myeloid-related proteins 8 and 14 complex, a novel ligand of toll-like receptor 4, and interleukin-1beta form a positive feedback mechanism in systemic-onset juvenile idiopathic arthritis. Arthritis Rheum. 2009;60:883\u201391.","journal-title":"Arthritis Rheum"},{"key":"8561_CR44","doi-asserted-by":"crossref","first-page":"480373","DOI":"10.1155\/2012\/480373","volume":"2012","author":"L Rossi-Semerano","year":"2012","unstructured":"Rossi-Semerano L, Kon\u00e9-Paut I. Is Still\u2019s disease an autoinflammatory syndrome? Int J Inflamm. 2012;2012:480373.","journal-title":"Int J Inflamm"},{"key":"8561_CR45","doi-asserted-by":"crossref","first-page":"136","DOI":"10.1016\/j.mehy.2012.04.009","volume":"79","author":"F Hayem","year":"2012","unstructured":"Hayem F, Hayem G. Still\u2019s disease and the mitochondrion: the other face of an old friend? Med Hypotheses. 2012;79:136\u20137.","journal-title":"Med Hypotheses"},{"key":"8561_CR46","first-page":"975","volume":"29","author":"Y Jamilloux","year":"2013","unstructured":"Jamilloux Y, Henry T. The inflammasomes: platforms of innate immunity. M\u00e9d Sci MS. 2013;29:975\u201384.","journal-title":"M\u00e9d Sci MS"},{"key":"8561_CR47","doi-asserted-by":"crossref","first-page":"981232","DOI":"10.1155\/2013\/981232","volume":"2013","author":"KM Antoniou","year":"2013","unstructured":"Antoniou KM, Margaritopoulos GA, Giannarakis I, Choulaki C, Fountoulakis N, Siafakas NM, et al. Adult onset Still\u2019s Disease: a case report with a rare clinical manifestation and pathophysiological correlations. Case Rep Med. 2013;2013:981232.","journal-title":"Case Rep Med"},{"key":"8561_CR48","doi-asserted-by":"crossref","first-page":"e261","DOI":"10.1038\/cddis.2011.132","volume":"3","author":"P Menu","year":"2012","unstructured":"Menu P, Mayor A, Zhou R, Tardivel A, Ichijo H, Mori K, et al. ER stress activates the NLRP3 inflammasome via an UPR-independent pathway. Cell Death Dis. 2012;3:e261.","journal-title":"Cell Death Dis"},{"key":"8561_CR49","doi-asserted-by":"crossref","first-page":"35886","DOI":"10.1074\/jbc.M113.514919","volume":"288","author":"JN Shin","year":"2013","unstructured":"Shin JN, Fattah EA, Bhattacharya A, Ko S, Eissa NT. Inflammasome activation by altered proteostasis. J Biol Chem. 2013;288:35886\u201395.","journal-title":"J Biol Chem"},{"key":"8561_CR50","first-page":"2320","volume":"28","author":"S Prahalad","year":"2001","unstructured":"Prahalad S, Kingsbury DJ, Griffin TA, Cooper BL, Glass DN, Maksymowych WP, et al. Polymorphism in the MHC-encoded LMP7 gene: association with JRA without functional significance for immunoproteasome assembly. J Rheumatol. 2001;28:2320\u20135.","journal-title":"J Rheumatol"},{"key":"8561_CR51","doi-asserted-by":"crossref","first-page":"505","DOI":"10.1016\/j.berh.2012.07.009","volume":"26","author":"S Savic","year":"2012","unstructured":"Savic S, Dickie LJ, Wittmann M, McDermott MF. Autoinflammatory syndromes and cellular responses to stress: pathophysiology, diagnosis and new treatment perspectives. Best Pract Res Clin Rheumatol. 2012;26:505\u201333.","journal-title":"Best Pract Res Clin Rheumatol"},{"key":"8561_CR52","doi-asserted-by":"crossref","first-page":"570","DOI":"10.1038\/nri3261","volume":"12","author":"H Park","year":"2012","unstructured":"Park H, Bourla AB, Kastner DL, Colbert RA, Siegel RM. Lighting the fires within: the cell biology of autoinflammatory diseases. Nat Rev Immunol. 2012;12:570\u201380.","journal-title":"Nat Rev Immunol"},{"key":"8561_CR53","doi-asserted-by":"crossref","unstructured":"Goldbach-Mansky R, Kastner DL. Autoinflammation: the prominent role of IL-1 in monogenic autoinflammatory diseases and implications for common illnesses. J Allergy Clin Immunol. 2009;124:1141\u20131149; quiz 1150\u20131151.","DOI":"10.1016\/j.jaci.2009.11.016"},{"key":"8561_CR54","doi-asserted-by":"crossref","first-page":"302","DOI":"10.1136\/ard.2007.076034","volume":"67","author":"T Lequerr\u00e9","year":"2008","unstructured":"Lequerr\u00e9 T, Quartier P, Rosellini D, Alaoui F, De Bandt M, Mejjad O, et al. Interleukin-1 receptor antagonist (anakinra) treatment in patients with systemic-onset juvenile idiopathic arthritis or adult onset Still disease: preliminary experience in France. Ann Rheum Dis. 2008;67:302\u20138.","journal-title":"Ann Rheum Dis"},{"key":"8561_CR55","doi-asserted-by":"crossref","first-page":"317820","DOI":"10.1155\/2012\/317820","volume":"2012","author":"C Giampietro","year":"2012","unstructured":"Giampietro C, Fautrel B. Anti-interleukin-1 agents in adult onset Still\u2019s disease. Int J Inflamm. 2012;2012:317820.","journal-title":"Int J Inflamm"},{"key":"8561_CR56","doi-asserted-by":"crossref","first-page":"545","DOI":"10.1002\/art.30128","volume":"63","author":"PA Nigrovic","year":"2011","unstructured":"Nigrovic PA, Mannion M, Prince FHM, Zeft A, Rabinovich CE, van Rossum MAJ, et al. Anakinra as first-line disease-modifying therapy in systemic juvenile idiopathic arthritis: report of forty-six patients from an international multicenter series. Arthritis Rheum. 2011;63:545\u201355.","journal-title":"Arthritis Rheum"},{"key":"8561_CR57","doi-asserted-by":"crossref","first-page":"1393","DOI":"10.1136\/ard.2003.016428","volume":"63","author":"T Rooney","year":"2004","unstructured":"Rooney T, Murphy E, Benito M, Roux-Lombard P, FitzGerald O, Dayer J-M, et al. Synovial tissue interleukin-18 expression and the response to treatment in patients with inflammatory arthritis. Ann Rheum Dis. 2004;63:1393\u20138.","journal-title":"Ann Rheum Dis"},{"key":"8561_CR58","doi-asserted-by":"crossref","first-page":"442","DOI":"10.1136\/ard.2008.093781","volume":"68","author":"P Conigliaro","year":"2009","unstructured":"Conigliaro P, Priori R, Bombardieri M, Alessandri C, Barone F, Pitzalis C, et al. Lymph node IL-18 expression in adult-onset Still\u2019s disease. Ann Rheum Dis. 2009;68:442\u20133.","journal-title":"Ann Rheum Dis"},{"key":"8561_CR59","first-page":"2189","volume":"31","author":"D-Y Chen","year":"2004","unstructured":"Chen D-Y, Lan J-L, Lin F-J, Hsieh T-Y. Proinflammatory cytokine profiles in sera and pathological tissues of patients with active untreated adult onset Still\u2019s disease. J Rheumatol. 2004;31:2189\u201398.","journal-title":"J Rheumatol"},{"key":"8561_CR60","doi-asserted-by":"crossref","first-page":"2732","DOI":"10.1002\/art.30451","volume":"63","author":"J-H Ryu","year":"2011","unstructured":"Ryu J-H, Yang S, Shin Y, Rhee J, Chun C-H, Chun J-S. Interleukin-6 plays an essential role in hypoxia-inducible factor 2\u03b1-induced experimental osteoarthritic cartilage destruction in mice. Arthritis Rheum. 2011;63:2732\u201343.","journal-title":"Arthritis Rheum"},{"key":"8561_CR61","doi-asserted-by":"crossref","first-page":"155","DOI":"10.1002\/acr.20319","volume":"63","author":"X Pu\u00e9chal","year":"2011","unstructured":"Pu\u00e9chal X, DeBandt M, Berthelot J-M, Breban M, Dubost J-J, Fain O, et al. Tocilizumab in refractory adult Still\u2019s disease. Arthritis Care Res. 2011;63:155\u20139.","journal-title":"Arthritis Care Res"},{"key":"8561_CR62","doi-asserted-by":"crossref","first-page":"49","DOI":"10.1007\/s10067-013-2381-5","volume":"33","author":"P Cipriani","year":"2014","unstructured":"Cipriani P, Ruscitti P, Carubbi F, Pantano I, Liakouli V, Berardicurti O, et al. Tocilizumab for the treatment of adult-onset Still\u2019s disease: results from a case series. Clin Rheumatol. 2014;33:49\u201355.","journal-title":"Clin Rheumatol"},{"key":"8561_CR63","doi-asserted-by":"crossref","first-page":"2385","DOI":"10.1056\/NEJMoa1112802","volume":"367","author":"F Benedetti De","year":"2012","unstructured":"De Benedetti F, Brunner HI, Ruperto N, Kenwright A, Wright S, Calvo I, et al. Randomized trial of tocilizumab in systemic juvenile idiopathic arthritis. N Engl J Med. 2012;367:2385\u201395.","journal-title":"N Engl J Med"},{"key":"8561_CR64","doi-asserted-by":"crossref","first-page":"42","DOI":"10.3109\/s10165-008-0115-3","volume":"19","author":"S Nakajima","year":"2009","unstructured":"Nakajima S, Naruto T, Miyamae T, Imagawa T, Mori M, Nishimaki S, et al. Improvement of reduced serum cartilage oligomeric matrix protein levels in systemic juvenile idiopathic arthritis patients treated with the anti-interleukin-6 receptor monoclonal antibody tocilizumab. Mod Rheumatol Jpn Rheum Assoc. 2009;19:42\u20136.","journal-title":"Mod Rheumatol Jpn Rheum Assoc"},{"key":"8561_CR65","first-page":"396","volume":"25","author":"T Hoshino","year":"1998","unstructured":"Hoshino T, Ohta A, Yang D, Kawamoto M, Kikuchi M, Inoue Y, et al. Elevated serum interleukin 6, interferon-gamma, and tumor necrosis factor-alpha levels in patients with adult Still\u2019s disease. J Rheumatol. 1998;25:396\u20138.","journal-title":"J Rheumatol"},{"key":"8561_CR66","doi-asserted-by":"crossref","first-page":"860","DOI":"10.1016\/j.immuni.2009.04.012","volume":"30","author":"G Meng","year":"2009","unstructured":"Meng G, Zhang F, Fuss I, Kitani A, Strober W. A mutation in the Nlrp3 gene causing inflammasome hyperactivation potentiates Th17 cell-dominant immune responses. Immunity. 2009;30:860\u201374.","journal-title":"Immunity"},{"key":"8561_CR67","doi-asserted-by":"crossref","first-page":"512","DOI":"10.1097\/ACI.0b013e32834c22f5","volume":"11","author":"AH Filipovich","year":"2011","unstructured":"Filipovich AH. The expanding spectrum of hemophagocytic lymphohistiocytosis. Curr Opin Allergy Clin Immunol. 2011;11:512\u20136.","journal-title":"Curr Opin Allergy Clin Immunol"},{"key":"8561_CR68","doi-asserted-by":"crossref","first-page":"940","DOI":"10.1038\/nri1983","volume":"6","author":"I Voskoboinik","year":"2006","unstructured":"Voskoboinik I, Smyth MJ, Trapani JA. Perforin-mediated target-cell death and immune homeostasis. Nat Rev Immunol. 2006;6:940\u201352.","journal-title":"Nat Rev Immunol"},{"key":"8561_CR69","doi-asserted-by":"crossref","first-page":"254","DOI":"10.1016\/S0167-5699(00)01622-4","volume":"21","author":"SE Stepp","year":"2000","unstructured":"Stepp SE, Mathew PA, Bennett M, de Saint Basile G, Kumar V. Perforin: more than just an effector molecule. Immunol Today. 2000;21:254\u20136.","journal-title":"Immunol Today"},{"key":"8561_CR70","doi-asserted-by":"crossref","first-page":"547","DOI":"10.1111\/j.1365-2133.2009.09549.x","volume":"162","author":"L Fardet","year":"2010","unstructured":"Fardet L, Galicier L, Vignon-Pennamen M-D, Regnier S, Noguera ME, de Labarthe A, et al. Frequency, clinical features and prognosis of cutaneous manifestations in adult patients with reactive haemophagocytic syndrome. Br J Dermatol. 2010;162:547\u201353.","journal-title":"Br J Dermatol"},{"key":"8561_CR71","doi-asserted-by":"crossref","first-page":"289","DOI":"10.1038\/gene.2012.3","volume":"13","author":"A Ravelli","year":"2012","unstructured":"Ravelli A, Grom AA, Behrens EM, Cron RQ. Macrophage activation syndrome as part of systemic juvenile idiopathic arthritis: diagnosis, genetics, pathophysiology and treatment. Genes Immun. 2012;13:289\u201398.","journal-title":"Genes Immun"},{"key":"8561_CR72","first-page":"1133","volume":"34","author":"EM Behrens","year":"2007","unstructured":"Behrens EM, Beukelman T, Paessler M, Cron RQ. Occult macrophage activation syndrome in patients with systemic juvenile idiopathic arthritis. J Rheumatol. 2007;34:1133\u20138.","journal-title":"J Rheumatol"},{"key":"8561_CR73","doi-asserted-by":"crossref","first-page":"305","DOI":"10.1007\/s10067-014-2487-4","volume":"33","author":"P Efthimiou","year":"2014","unstructured":"Efthimiou P, Kadavath S, Mehta B. Life-threatening complications of adult-onset Still\u2019s disease. Clin Rheumatol. 2014;33:305\u201314.","journal-title":"Clin Rheumatol"},{"key":"8561_CR74","doi-asserted-by":"crossref","first-page":"441","DOI":"10.1093\/rheumatology\/kep418","volume":"49","author":"SJ Vastert","year":"2010","unstructured":"Vastert SJ, van Wijk R, D\u2019Urbano LE, de Vooght KMK, de Jager W, Ravelli A, et al. Mutations in the perforin gene can be linked to macrophage activation syndrome in patients with systemic onset juvenile idiopathic arthritis. Rheumatology. 2010;49:441\u20139.","journal-title":"Rheumatology"},{"key":"8561_CR75","doi-asserted-by":"crossref","first-page":"2892","DOI":"10.1002\/art.23734","volume":"58","author":"K Zhang","year":"2008","unstructured":"Zhang K, Biroschak J, Glass DN, Thompson SD, Finkel T, Passo MH, et al. Macrophage activation syndrome in patients with systemic juvenile idiopathic arthritis is associated with MUNC13-4 polymorphisms. Arthritis Rheum. 2008;58:2892\u20136.","journal-title":"Arthritis Rheum"},{"key":"8561_CR76","doi-asserted-by":"crossref","first-page":"769","DOI":"10.3899\/jrheum.100655","volume":"38","author":"M Yanagimachi","year":"2011","unstructured":"Yanagimachi M, Naruto T, Miyamae T, Hara T, Kikuchi M, Hara R, et al. Association of IRF5 polymorphisms with susceptibility to macrophage activation syndrome in patients with juvenile idiopathic arthritis. J Rheumatol. 2011;38:769\u201374.","journal-title":"J Rheumatol"},{"key":"8561_CR77","doi-asserted-by":"crossref","first-page":"R30","DOI":"10.1186\/ar1453","volume":"7","author":"J Villanueva","year":"2005","unstructured":"Villanueva J, Lee S, Giannini EH, Graham TB, Passo MH, Filipovich A, et al. Natural killer cell dysfunction is a distinguishing feature of systemic onset juvenile rheumatoid arthritis and macrophage activation syndrome. Arthritis Res Ther. 2005;7:R30\u20137.","journal-title":"Arthritis Res Ther"},{"key":"8561_CR78","doi-asserted-by":"crossref","first-page":"2868","DOI":"10.1002\/art.34514","volume":"64","author":"S-J Lee","year":"2012","unstructured":"Lee S-J, Cho Y-N, Kim T-J, Park S-C, Park D-J, Jin H-M, et al. Natural killer T cell deficiency in active adult-onset Still\u2019s Disease: correlation of deficiency of natural killer T cells with dysfunction of natural killer cells. Arthritis Rheum. 2012;64:2868\u201377.","journal-title":"Arthritis Rheum"},{"key":"8561_CR79","doi-asserted-by":"crossref","first-page":"2000","DOI":"10.3899\/jrheum.111500","volume":"39","author":"JH Park","year":"2012","unstructured":"Park JH, Kim H-S, Lee JS, Kim JJ, Jung K-H, Park Y-W, et al. Natural killer cell cytolytic function in Korean patients with adult-onset Still\u2019s disease. J Rheumatol. 2012;39:2000\u20137.","journal-title":"J Rheumatol"},{"key":"8561_CR80","doi-asserted-by":"crossref","first-page":"273","DOI":"10.1016\/j.clim.2012.03.004","volume":"143","author":"M Shimizu","year":"2012","unstructured":"Shimizu M, Sakakibara Y, Kawano M, Yachie A. Transient impairment of NK cell function in an infant born to a mother with adult-onset Still\u2019s disease: perinatal effect of maternal IL-18. Clin Immunol. 2012;143:273\u20134.","journal-title":"Clin Immunol"},{"key":"8561_CR81","doi-asserted-by":"crossref","first-page":"2782","DOI":"10.1002\/art.24750","volume":"60","author":"W Jager De","year":"2009","unstructured":"De Jager W, Vastert SJ, Beekman JM, Wulffraat NM, Kuis W, Coffer PJ, et al. Defective phosphorylation of interleukin-18 receptor beta causes impaired natural killer cell function in systemic-onset juvenile idiopathic arthritis. Arthritis Rheum. 2009;60:2782\u201393.","journal-title":"Arthritis Rheum"},{"key":"8561_CR82","doi-asserted-by":"crossref","first-page":"3483","DOI":"10.1182\/blood-2005-05-1980","volume":"106","author":"K Mazodier","year":"2005","unstructured":"Mazodier K, Marin V, Novick D, Farnarier C, Robitail S, Schleinitz N, et al. Severe imbalance of IL-18\/IL-18BP in patients with secondary hemophagocytic syndrome. Blood. 2005;106:3483\u20139.","journal-title":"Blood"},{"key":"8561_CR83","doi-asserted-by":"crossref","first-page":"1645","DOI":"10.1093\/rheumatology\/keq133","volume":"49","author":"M Shimizu","year":"2010","unstructured":"Shimizu M, Yokoyama T, Yamada K, Kaneda H, Wada H, Wada T, et al. Distinct cytokine profiles of systemic-onset juvenile idiopathic arthritis-associated macrophage activation syndrome with particular emphasis on the role of interleukin-18 in its pathogenesis. Rheumatology. 2010;49:1645\u201353.","journal-title":"Rheumatology"},{"key":"8561_CR84","doi-asserted-by":"crossref","first-page":"1648","DOI":"10.1182\/blood-2004-08-2997","volume":"105","author":"AD Billiau","year":"2005","unstructured":"Billiau AD, Roskams T, Van Damme-Lombaerts R, Matthys P, Wouters C. Macrophage activation syndrome: characteristic findings on liver biopsy illustrating the key role of activated, IFN-gamma-producing lymphocytes and IL-6- and TNF-alpha-producing macrophages. Blood. 2005;105:1648\u201351.","journal-title":"Blood"},{"issue":"Suppl 11","key":"8561_CR85","doi-asserted-by":"crossref","first-page":"S203","DOI":"10.1002\/art.38583","volume":"66","author":"S Canna","year":"2014","unstructured":"Canna S, de Jesus AA, Deng Z, Gouni S, Marrero B, Brooks S, et al. A157: macrophage activation syndrome-like illness due to an activating mutation in NLRC4. Arthritis Rheumatol. 2014;66(Suppl 11):S203.","journal-title":"Arthritis Rheumatol"},{"key":"8561_CR86","doi-asserted-by":"crossref","first-page":"3793","DOI":"10.1002\/art.22981","volume":"56","author":"N Fall","year":"2007","unstructured":"Fall N, Barnes M, Thornton S, Luyrink L, Olson J, Ilowite NT, et al. Gene expression profiling of peripheral blood from patients with untreated new-onset systemic juvenile idiopathic arthritis reveals molecular heterogeneity that may predict macrophage activation syndrome. Arthritis Rheum. 2007;56:3793\u2013804.","journal-title":"Arthritis Rheum"},{"key":"8561_CR87","doi-asserted-by":"crossref","first-page":"589","DOI":"10.1136\/ard.2006.061853","volume":"66","author":"W Jager De","year":"2007","unstructured":"De Jager W, Hoppenreijs EPAH, Wulffraat NM, Wedderburn LR, Kuis W, Prakken BJ. Blood and synovial fluid cytokine signatures in patients with juvenile idiopathic arthritis: a cross-sectional study. Ann Rheum Dis. 2007;66:589\u201398.","journal-title":"Ann Rheum Dis"},{"key":"8561_CR88","doi-asserted-by":"crossref","first-page":"362","DOI":"10.1016\/j.clim.2011.12.008","volume":"142","author":"C Macaubas","year":"2012","unstructured":"Macaubas C, Nguyen KD, Peck A, Buckingham J, Deshpande C, Wong E, et al. Alternative activation in systemic juvenile idiopathic arthritis monocytes. Clin Immunol. 2012;142:362\u201372.","journal-title":"Clin Immunol"},{"key":"8561_CR89","doi-asserted-by":"crossref","first-page":"257","DOI":"10.1016\/j.clim.2010.04.003","volume":"136","author":"S Srivastava","year":"2010","unstructured":"Srivastava S, Macaubas C, Deshpande C, Alexander HC, Chang S-Y, Sun Y, et al. Monocytes are resistant to apoptosis in systemic juvenile idiopathic arthritis. Clin Immunol. 2010;136:257\u201368.","journal-title":"Clin Immunol"},{"key":"8561_CR90","doi-asserted-by":"crossref","first-page":"370","DOI":"10.3109\/03008200903461462","volume":"51","author":"D-Y Chen","year":"2010","unstructured":"Chen D-Y, Chen Y-M, Chen H-H, Hsieh C-W, Lin C-C, Lan J-L. The associations of circulating CD4\u00a0+\u00a0CD25high regulatory T cells and TGF-\u03b2 with disease activity and clinical course in patients with adult-onset Still\u2019s disease. Connect Tissue Res. 2010;51:370\u20137.","journal-title":"Connect Tissue Res"},{"key":"8561_CR91","doi-asserted-by":"crossref","first-page":"206","DOI":"10.1016\/j.clim.2009.09.010","volume":"134","author":"C Macaubas","year":"2010","unstructured":"Macaubas C, Nguyen K, Deshpande C, Phillips C, Peck A, Lee T, et al. Distribution of circulating cells in systemic juvenile idiopathic arthritis across disease activity states. Clin Immunol. 2010;134:206\u201316.","journal-title":"Clin Immunol"},{"key":"8561_CR92","doi-asserted-by":"crossref","first-page":"185","DOI":"10.1186\/1741-7015-11-185","volume":"11","author":"C Ros\u00e1rio","year":"2013","unstructured":"Ros\u00e1rio C, Zandman-Goddard G, Meyron-Holtz EG, D\u2019Cruz DP, Shoenfeld Y. The hyperferritinemic syndrome: macrophage activation syndrome, Still\u2019s disease, septic shock and catastrophic antiphospholipid syndrome. BMC Med. 2013;11:185.","journal-title":"BMC Med"},{"key":"8561_CR93","first-page":"298405","volume":"2012","author":"B Mehta","year":"2012","unstructured":"Mehta B, Efthimiou P. Ferritin in adult-onset still\u2019s disease: just a useful innocent bystander? Int J Inflamm. 2012;2012:298405.","journal-title":"Int J Inflamm"},{"key":"8561_CR94","doi-asserted-by":"crossref","first-page":"887","DOI":"10.1002\/hep.22716","volume":"49","author":"RG Ruddell","year":"2009","unstructured":"Ruddell RG, Hoang-Le D, Barwood JM, Rutherford PS, Piva TJ, Watters DJ, et al. Ferritin functions as a proinflammatory cytokine via iron-independent protein kinase C zeta\/nuclear factor kappaB\u2014regulated signaling in rat hepatic stellate cells. Hepatology. 2009;49:887\u2013900.","journal-title":"Hepatology"},{"key":"8561_CR95","doi-asserted-by":"crossref","first-page":"562","DOI":"10.1016\/S0140-6736(87)90204-2","volume":"1","author":"T Ota","year":"1987","unstructured":"Ota T, Higashi S, Suzuki H, Eto S. Increased serum ferritin levels in adult Still\u2019s disease. Lancet. 1987;1:562\u20133.","journal-title":"Lancet"},{"key":"8561_CR96","doi-asserted-by":"crossref","first-page":"194","DOI":"10.1097\/00005792-200205000-00003","volume":"81","author":"B Fautrel","year":"2002","unstructured":"Fautrel B, Zing E, Golmard J-L, Le Moel G, Bissery A, Rioux C, et al. Proposal for a new set of classification criteria for adult-onset still disease. Medicine. 2002;81:194\u2013200.","journal-title":"Medicine"},{"key":"8561_CR97","doi-asserted-by":"crossref","first-page":"345","DOI":"10.1016\/j.cyto.2012.11.025","volume":"61","author":"M Shimizu","year":"2013","unstructured":"Shimizu M, Nakagishi Y, Yachie A. Distinct subsets of patients with systemic juvenile idiopathic arthritis based on their cytokine profiles. Cytokine. 2013;61:345\u20138.","journal-title":"Cytokine"},{"key":"8561_CR98","doi-asserted-by":"crossref","unstructured":"Ichida H, Kawaguchi Y, Sugiura T, Takagi K, Katsumata Y, Gono T, et al. Clinical manifestations of adult-onset still\u2019s disease presenting with erosive arthritis: association with low levels of ferritin and IL-18. Arthritis Care Res (Hoboken). 2013. doi: 10.1002\/acr.22194 .","DOI":"10.1002\/acr.22194"},{"key":"8561_CR99","doi-asserted-by":"crossref","first-page":"1072","DOI":"10.1002\/art.38362","volume":"66","author":"SW Canna","year":"2014","unstructured":"Canna SW. Interferon- \u03b3: friend or foe in systemic juvenile idiopathic arthritis and adult Still\u2019s Disease. Arthritis Rheumatol. 2014;66:1072\u20136.","journal-title":"Arthritis Rheumatol"},{"key":"8561_CR100","first-page":"511","volume":"31","author":"S Tanaka","year":"1991","unstructured":"Tanaka S, Matsumoto Y, Ohnishi H, Maeda M, Nishioka K, Kashiwazaki S, et al. Comparison of clinical features of childhood and adult onset Still\u2019s disease. Ry\u016bmachi Rheum. 1991;31:511\u20138.","journal-title":"Ry\u016bmachi Rheum"}],"container-title":["Immunologic Research"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s12026-014-8561-9.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s12026-014-8561-9\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s12026-014-8561-9","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,8,17]],"date-time":"2019-08-17T07:43:10Z","timestamp":1566027790000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s12026-014-8561-9"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2014,11,12]]},"references-count":100,"journal-issue":{"issue":"1-2","published-print":{"date-parts":[[2015,2]]}},"alternative-id":["8561"],"URL":"https:\/\/doi.org\/10.1007\/s12026-014-8561-9","relation":{},"ISSN":["0257-277X","1559-0755"],"issn-type":[{"value":"0257-277X","type":"print"},{"value":"1559-0755","type":"electronic"}],"subject":[],"published":{"date-parts":[[2014,11,12]]}}}